A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
Clinical trial NCT05683457 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05683457
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2027-03-06
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.